Home Profile My research Publications Outreach Animations Funders Contact me

Nanomatrices to be used as smart platforms for effective, non-invasive and highly targeted therapies


Watch this space for ‘less text heavy’ content

The MOZART project involves 8 different countries and 11 partners, 5 high tech SMEs and 6 top European Universities. The concept behind MOZART is to develop a library of inorganic nanomatrices to be used as smart platforms for effective, non-invasive and highly targeted therapies to treat delayed bone healing and non-healing chronic skin wounds, which are both characterised by an inflammation and often infection. Mesoporous therapeutic glasses, doped with selected ions, will be synthesised and then loaded with the chosen payload. Ordered mesoporous carbons will also be manufactured to host a wide range of biomolecules and higher payload. As in an orchestra, where the integration among the different participants allows a harmonious symphony to be created, in MOZART the synergistic release of ions and drugs will be directed to achieve a radically improved therapeutic effect. Mozart aims to translate these new and innovative medical products into the clinic and market for the benefit of the patients and the industrial healthcare sector in Europe.

The potential impact of MOZART is enormous as in EU alone, 350 000 patients per year suffer delayed or non-union bone fractures and 2.2 million patients suffer from chronic non-healing wounds.